Drug distribution in blood, defined as drug blood-to-plasma concentration ratio (R-b), is a fundamental pharmacokinetic parameter. it relates the plasma clearance to the blood clearance, enabling the physiological interpretation of this parameter. Although easily experimentally deter-mined, Rb values are lacking for the vast majority of drugs. We present a systematic approach using mechanistic, partial least squares (PLS) regression and artificial neural network (ANN) models to relate various in vitro and in silico molecular descriptors to a dataset of 93 drug Rb values collected in the literature. The ANN model resulted in the best overall approach, with r(2) = 0.927 and r(2) = 0.871 for the train and the test sets, respectively. PLS regre...
Predicting the fraction unbound in plasma provides a good understanding of the pharmacokinetic prope...
The ability to generate predictive models linking the in vitro assessment of pharmaceutical products...
Drug development targeting the central nervous system (CNS) is challenging due to poor predictabilit...
An important goal for drug development within the pharmaceutical industry is the application of simp...
Early pharmacokinetic optimisation is a key principle in drug discovery and development. Modeling ab...
Artificial Intelligence Lab, Department of MIS, University of ArizonaPredicting blood concentration ...
Since the majority of lead compounds identified for drug clinical trials fail to reach the market du...
The goal of quantitative structure-pharmacokinetic relationship analyses is to develop useful models...
Use of in vitro suspensions of human hepatocytes is currently accepted as one of the most promising ...
Volume of distribution and fraction unbound are two key parameters in pharmacokinetics. The fraction...
Most drugs are excreted into breast milk to some extent and are bioavailable to the infant. The abil...
Artificial Intelligence Lab, Department of MIS, University of ArizonaThis research examined the appl...
Poor pharmacokinetic and toxicity profiles are major reasons for the low rate of advancing lead drug...
During the development of a pharmaceutical formulation, a powerful tool is needed to extract the key...
For the prediction of decay concentration profiles of the p-boronophenylalanine (BPA) in blood durin...
Predicting the fraction unbound in plasma provides a good understanding of the pharmacokinetic prope...
The ability to generate predictive models linking the in vitro assessment of pharmaceutical products...
Drug development targeting the central nervous system (CNS) is challenging due to poor predictabilit...
An important goal for drug development within the pharmaceutical industry is the application of simp...
Early pharmacokinetic optimisation is a key principle in drug discovery and development. Modeling ab...
Artificial Intelligence Lab, Department of MIS, University of ArizonaPredicting blood concentration ...
Since the majority of lead compounds identified for drug clinical trials fail to reach the market du...
The goal of quantitative structure-pharmacokinetic relationship analyses is to develop useful models...
Use of in vitro suspensions of human hepatocytes is currently accepted as one of the most promising ...
Volume of distribution and fraction unbound are two key parameters in pharmacokinetics. The fraction...
Most drugs are excreted into breast milk to some extent and are bioavailable to the infant. The abil...
Artificial Intelligence Lab, Department of MIS, University of ArizonaThis research examined the appl...
Poor pharmacokinetic and toxicity profiles are major reasons for the low rate of advancing lead drug...
During the development of a pharmaceutical formulation, a powerful tool is needed to extract the key...
For the prediction of decay concentration profiles of the p-boronophenylalanine (BPA) in blood durin...
Predicting the fraction unbound in plasma provides a good understanding of the pharmacokinetic prope...
The ability to generate predictive models linking the in vitro assessment of pharmaceutical products...
Drug development targeting the central nervous system (CNS) is challenging due to poor predictabilit...